Current Infectious Disease Reports

Current Infectious Disease Reports is a review journal that Springer has published since 1999, commissioning international specialists to weigh recent clinical findings on infection, and its 2025 Journal Impact Factor is 2.4.《当前传染病报告》是 Springer 自 1999 年起出版的综述型期刊，请国际专家权衡传染病领域的新近临床发现，2025 年期刊影响因子 2.4。

Scope

• Only review material appears. Primary studies, case reports and trial protocols fall outside the remit, so readers come for synthesis rather than for data nobody has gathered before.刊物只登综述性稿件，原始研究、病例报告与试验方案都不在受理之列，读者来此取的是综合梳理，而非另起一炉的新数据。

• Each article is built around one clinical question about diagnosis, treatment, management or prevention, and authors must say plainly where the evidence thins out and where practice outruns it.每篇文章围绕一个临床问题展开，题面落在诊断与治疗，也落在管理与预防，作者须直说证据何处变薄，实践又在何处跑到证据前头。

• Antimicrobial development and drug resistance carry the heaviest load of the nine standing sections, taking new agents, pharmacokinetics, stewardship and the resistant organisms that keep outrunning all three.抗微生物药物研发与耐药是 9 个常设分栏里负担最重的一栏，新药与药代动力学在此，抗菌药物管理与不断跑赢前三者的耐药菌也在此。

• Healthcare-associated infections take in device-related bloodstream infection, surgical site infection and Clostridioides difficile, along with the environmental cleaning failures that filovirus outbreaks in under-resourced hospitals tend to expose first.医疗相关感染收入器械相关血流感染与手术部位感染，艰难梭菌同样在内，资源匮乏地区医院里由丝状病毒疫情暴露的环境清洁短板也归此栏。

• HIV and AIDS hold a section of their own, and the aims page names sexually transmitted diseases beside tropical and travel medicine and urinary tract infections as ground it means to cover.HIV 与艾滋病单设一栏，宗旨页把性传播疾病与热带及旅行医学并列，也把尿路感染列为刊物要覆盖的领域。

• Intra-abdominal infections, hepatitis and gastroenteritis share one section, where the recent output runs from novel antibiotic combinations for complicated infection to hepatitis B reactivation under targeted cancer therapy.腹腔感染与肝炎、胃肠炎共用一栏，近期稿件从复杂性感染的新型抗生素联合方案，写到靶向抗癌治疗下的乙肝病毒再激活。

• Neurological infections form a separate heading, covering bacterial meningitis, viral encephalitis, brain abscess and the infections that complicate neurosurgery, transplantation or a long stay in intensive care.神经系统感染另立一栏，细菌性脑膜炎、病毒性脑炎与脑脓肿都在其中，神经外科与移植术后以及长期重症监护中并发的感染同样受理。

• Sepsis in the intensive care unit has a section and a standing collection, both built around how management choices made in the unit shape survival and later recovery.重症监护中的脓毒症既有分栏又有常设合集，两者都围绕监护室内的处置选择如何影响存活与后续康复。

• Skin, soft tissue, bone and joint infections cover necrotising soft tissue infection, osteomyelitis, prosthetic joint infection and the adjunctive treatments, hyperbaric oxygen among them, that reviewers keep reassessing.皮肤与软组织及骨关节感染一栏覆盖坏死性软组织感染，也覆盖骨髓炎与假体关节感染，连同高压氧等被反复重估的辅助疗法。

• Transplant and oncology infectious disease is handled as its own field, from neutropenic fever and invasive mould infection to the viral reactivation that follows stem cell transplant or cellular therapy.移植与肿瘤感染自成一域，从粒细胞缺乏性发热与侵袭性霉菌感染，到干细胞移植或细胞治疗后出现的病毒再激活。

• Tropical, travel and emerging infections carry the outbreak side of the field, taking rickettsial disease, arboviral spread, imported fever and the disinfection problems that filovirus epidemics create in conflict zones.热带与旅行及新发感染承担领域的疫情一侧，立克次体病与虫媒病毒扩散在列，输入性发热与丝状病毒疫情在冲突地区造成的消毒难题也在其中。

• Every review ends with an annotated reference list, a house requirement that marks out the few papers worth reading and says in a line or two why each one matters.每篇综述都以带注释的参考文献表收尾，这是刊物的硬性要求，标出少数值得一读的论文，并用一两句话说明各篇为何要紧。

• Commentaries by established figures sit alongside the reviews, short commissioned pieces in which a senior clinician states a position on a contested question rather than summarising the literature around it.知名学者的评论与综述并列，篇幅短小，资深临床医生在其中就一个有争议的问题表明立场，而不去综述周边的文献。

• Section editors choose the topics and hand them to named experts, so the contents of a volume reflect what a small group of specialists judged urgent that year.分栏编辑选定题目再交给具名专家执笔，因此一卷的目录反映的是这一小群专家当年判定为紧迫的内容。

• An international board reviews the annual table of contents and suggests articles of special interest to its own country or region, a step meant to keep topics current while they are still moving.国际编委会审读年度目录，并就本国或本地区特别关注的题目提出建议，这一步意在让选题跟上仍在变动的研究。

History

• The first volume is dated 1999, brought out from Philadelphia by Current Science Inc., the imprint the National Library of Medicine still records today as the original publisher.第 1 卷标注 1999 年，由费城的 Current Science Inc. 出版，美国国家医学图书馆至今把这家机构记为原出版方。

• Volume 1 carried the 1999 year, and the count has moved exactly one volume a year without a break since then, so volume 22 covers the whole of 2020 while volume 28 now reaches 2026.第 1 卷对应 1999 年，此后卷号逐年递进未曾中断，第 22 卷落在 2020 年，第 28 卷走到 2026 年。

• Ownership passed to Springer, whose New York imprint now appears in the National Library of Medicine record, and the copyright line reads Springer Science+Business Media, part of Springer Nature.刊物后来归入 Springer，美国国家医学图书馆的现行出版方记录已写作纽约的 Springer US，版权行署 Springer Science+Business Media，隶属 Springer Nature。

• The journal page lists a single number, the electronic ISSN 1534-3146, while Crossref also carries 1523-3847, a separate print number the title was given when it first launched in 1999.刊页只列一个刊号，即电子刊号 1534-3146，Crossref 另记 1523-3847，那是 1999 年创刊时配给的印刷刊号。

• The name belongs to Springer's Current Reports series of review journals, each devoted to one clinical field and filled volume by volume with commissioned rather than submitted work.刊名属于 Springer 的 Current Reports 综述刊系列，每一份只守一个临床领域，内容按卷由组稿而来，而非自由来稿。

• Twelve parts a year became the settled pattern in the 2020s, and Crossref lists issues 1 through 12 for each of the four years from 2021 to 2024, numbered monthly from January.2020 年代形成一年 12 期的格局，Crossref 显示 2021 至 2024 年每年都编到第 12 期，按月份逐期排下来。

• Volume 27, dated 2025, dropped the monthly parts altogether. The whole year appeared as a single issue, and its eighteen articles were numbered as articles rather than paginated inside parts.2025 年的第 27 卷取消月度分册，全年只出一期，18 篇文章按文章编号编排，不再在分册内另编页码。

• Volume 28 has followed the same course through 2026 and stands at article 22 by late October, each paper going online on its own date rather than on an issue date.第 28 卷沿同一制度走到 2026 年，10 月下旬已编到第 22 号，各篇按自己的上线日期发布，不再等某个期号。

• Topical collections now organise the contents, among them sepsis in intensive care, healthcare-associated infection, and tropical, travel and emerging infection, each with its own open call and no closing date.专题合集如今充当目录骨架，重症监护中的脓毒症、医疗相关感染与热带及旅行和新发感染各有其一，各自公开征稿且不设截止期。

• PubMed coverage stops at volume 22, issue 3, the March 2020 number, and the National Library of Medicine records nothing at all after that point, the title never having entered MEDLINE.PubMed 的收录止于第 22 卷第 3 期，即 2020 年 3 月号，美国国家医学图书馆此后再无记录，该刊也从未进入 MEDLINE。

• Clarivate keeps it in Science Citation Index Expanded, and the publisher's list adds Scopus, EMBASE, CAB Abstracts, Reaxys and ProQuest, which carry the title to pharmacological and agricultural readers.Clarivate 把它收在 Science Citation Index Expanded，出版方清单另有 Scopus，也有 EMBASE 与 CAB Abstracts，Reaxys 和 ProQuest 同样在列。

• The impact factor has slid from 3.663 in 2022 to 3.1 a year later, then to 2.9, reaching 2.4 in 2025, against a five-year figure of 3.6 and a cited half-life still standing at 8.4 years.影响因子从 2022 年的 3.663 降到 3.1，再降到 2.9，2025 年为 2.4，五年影响因子 3.6，被引半衰期 8.4 年。

• In the 2025 release it ranks 80th among 141 titles in infectious diseases, carrying 1,826 citations, while gold open access accounts for 40.79 percent of all the papers it has published lately.2025 年的榜单把它排在传染病学 141 种期刊的第 80 位，累计被引 1826 次，金色开放获取占近年发文的 40.79%。

Editors

• Horacio Bach is editor-in-chief and works from the Vancouver Coastal Health Institute at the University of British Columbia in Vancouver, where the masthead places him alone at the top.Horacio Bach 是主编，任职于温哥华的不列颠哥伦比亚大学（University of British Columbia）下属的 Vancouver Coastal Health Institute，刊头之首只有他一人。

• No deputy editor is named beside him. The next tier is the section editors, and below them a board of twenty-seven whose names fill out the masthead.主编之下未设副主编，再下一层是分栏编辑，最外层是 27 人的编委会，刊头由这些名字撑起。

• Those twenty-seven come from thirteen countries, from Peru, Brazil and Canada to Kenya, Saudi Arabia, Japan and Russia, and thirteen of them work in the United States.这 27 人来自 13 个国家，从秘鲁与巴西到肯尼亚与沙特阿拉伯，日本与俄罗斯也在其中，有 13 人在美国工作。

• Nine subject sections carry the commissioning, each with a named editor or a pair of them, and thirteen people hold those posts between them, from Baltimore to Brisbane.组稿依托 9 个学科分栏，每栏有一名或两名具名编辑，13 人分任其职，从巴尔的摩排到布里斯班。

• Antimicrobial development and drug resistance is shared by Kimberly Claeys of the University of Maryland in Baltimore and Jordan Smith of High Point University in North Carolina.抗微生物药物研发与耐药由马里兰大学巴尔的摩分校的 Kimberly Claeys 与北卡罗来纳州高点大学（High Point University）的 Jordan Smith 共同主持。

• Healthcare-associated infection belongs to Patrick Ching and Barry Rittmann, both of Virginia Commonwealth University Health in Richmond, a health system in which hospital infection control is a daily concern.医疗相关感染由弗吉尼亚联邦大学医疗系统的 Patrick Ching 与 Barry Rittmann 主持，两人都在里士满，院内感染控制在那里是日常事务。

• Cecilia Yoon of Cornell University takes HIV and AIDS, while Theodore Steiner of the University of British Columbia in Vancouver takes intra-abdominal infection together with hepatitis and gastroenteritis.HIV 与艾滋病归康奈尔大学的 Cecilia Yoon，腹腔感染与肝炎及胃肠炎归温哥华的不列颠哥伦比亚大学的 Theodore Steiner。

• Neurological infection is handled by Yun Huang at the University of Liverpool, and sepsis in intensive care by Jeffrey Lipman at the University of Queensland in Brisbane.神经系统感染由利物浦大学的 Yun Huang 负责，重症监护中的脓毒症由布里斯班昆士兰大学的 Jeffrey Lipman 负责。

• Skin, soft tissue, bone and joint infection sits with Ambar Haleem and Nasia Safdar, both at the University of Wisconsin in Madison, and transplant and oncology with Andrea Lombardi in Milan.皮肤与软组织及骨关节感染由威斯康星大学麦迪逊分校的 Ambar Haleem 与 Nasia Safdar 共同负责，移植与肿瘤感染交给米兰的 Andrea Lombardi。

• Tropical, travel and emerging infection is the widest brief, split between Lin Chen of Mount Auburn Hospital in Cambridge, Massachusetts, and Francesca Norman at the Ramón y Cajal hospital in Madrid.热带与旅行及新发感染的范围最宽，由马萨诸塞州剑桥市奥本山医院的 Lin Chen 与马德里拉蒙·卡哈尔医院的 Francesca Norman 分担。

• Review is single-blind. Referees see who wrote the paper, their reports reach authors without a name attached, and the model is defended as the one reviewers know best.评审采用单盲制，审稿人看得到作者是谁，意见回到作者手里时不署名，刊物把这一制度解释为审稿人最熟悉的方式。

• Manuscripts pass a plagiarism check, then go to one or two section editors or board members chosen for their expertise in the topic, who may bring in outside referees.稿件先过查重，再交给一至两名对口的分栏编辑或编委，必要时另请外部审稿人补一层意见。

• Submissions are by invitation only, as the author instructions state. The types taken are reviews and invited commentaries, with an abstract of 150 to 250 words and four to six keywords.投稿须经邀约，作者指南对此写得很直白，受理体裁是综述与受邀评论，摘要 150 至 250 词，关键词 4 至 6 个。

• Authors wait a median of three days for a first decision, and the journal counted 206,400 full-text downloads across 2025, with 65 of its articles sitting open access under the hybrid model.首次决定的中位时间为 3 天，站点统计 2025 年下载量 20.64 万次，其中 65 篇为开放获取文章。

• An editor or board member who appears among the authors steps out of the handling entirely, and a colleague or two outside referees take the paper instead.主编、分栏编辑或编委若出现在作者名单里，本人完全退出该稿流程，改由同事或两名外部审稿人接手。